Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer
Authors
Keywords
-
Journal
Immunotherapy
Volume 2, Issue 3, Pages 347-365
Publisher
Future Medicine Ltd
Online
2010-05-10
DOI
10.2217/imt.10.16
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study
- (2010) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Chemokine–chemokine receptors in cancer immunotherapy
- (2010) Trina J Stewart et al. Immunotherapy
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Neutralization of interferon-α/β-inducible genes and downstream effect in a phase I trial of an anti-interferon-α monoclonal antibody in systemic lupus erythematosus
- (2009) Yihong Yao et al. ARTHRITIS AND RHEUMATISM
- Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study
- (2009) Jason W. Bauer et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers
- (2009) Barbara White et al. CLINICAL THERAPEUTICS
- Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration
- (2009) Thomas A Ciulla et al. CURRENT OPINION IN OPHTHALMOLOGY
- Anti-Cytokine Therapeutics: History and Update
- (2009) Rojo Ratsimandresy et al. CURRENT PHARMACEUTICAL DESIGN
- Characterization and potential clinical applications of autoantibodies against cytokines
- (2009) Carina de Lemos Rieper et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Briakinumab
- (2009) Xinaida Taligare Lima et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study
- (2009) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- Golimumab
- (2009) Dimitrios A. Pappas et al. NATURE REVIEWS DRUG DISCOVERY
- Type 17 T helper cells—origins, features and possible roles in rheumatic disease
- (2009) Francesco Annunziato et al. Nature Reviews Rheumatology
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Review of a Panitumumab (VectibixTM) Clinical Trial for First-Line Treatment of Metastatic Colorectal Cancer
- (2009) R. M. Giusti et al. ONCOLOGIST
- Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer
- (2009) Alberto Sobrero et al. ONCOLOGY
- IFN kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model
- (2009) D. Zagury et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids
- (2009) J. Grunewald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease
- (2009) M. Britschgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies
- (2009) Klaus Bendtzen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
- (2009) Frank Hoentjen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
- (2009) Andrea Rubbert-Roth et al. ARTHRITIS RESEARCH & THERAPY
- Active immunization to tumor necrosis factor-α is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis
- (2009) Laure Delavallée et al. ARTHRITIS RESEARCH & THERAPY
- Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4
- (2009) Sujata Sarkar et al. ARTHRITIS RESEARCH & THERAPY
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- (2008) D Albert et al. ANNALS OF THE RHEUMATIC DISEASES
- Lack of association between the interferon- signature and longitudinal changes in disease activity in systemic lupus erythematosus
- (2008) C Landolt-Marticorena et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
- (2008) Gary T. Jennings et al. Annual Review of Pharmacology and Toxicology
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Dendritic cells and cytokines in human inflammatory and autoimmune diseases
- (2008) P BLANCO et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis
- (2008) Gunther Spohn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus
- (2008) Martin Aringer et al. Expert Opinion On Drug Safety
- Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma
- (2008) Bernard Escudier et al. Expert Review of Anticancer Therapy
- Emerging applications of anticytokine vaccines
- (2008) Laure Delavallée et al. Expert Review of Vaccines
- Regulatory T cells (Treg) in rheumatoid arthritis
- (2008) Marie-Christophe Boissier et al. JOINT BONE SPINE
- Crohn's disease: beyond antagonists of tumour necrosis factor
- (2008) Laurent Peyrin-Biroulet et al. LANCET
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Mucosal cytokine network in inflammatory bowel disease
- (2008) Akira Andoh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started